Aspirin protects women at risk of pre-eclampsia without causing bleeding

doi:10.1136/bmj.327.7424.0-h

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Question Does aspirin prevent pre-eclampsia and associated complications in high risk women?

Synopsis For this meta-analysis the authors sought high quality randomised controlled trials of low dose (by any definition) aspirin versus placebo for the prevention of pre-eclampsia and associated outcomes in women at high risk of pre-eclampsia by history. Risk factors were previous pre-eclampsia, chronic (pre-existing) hypertension, diabetes, renal disease, …